🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DFT
$DFTX
🔒 US EquitiesDefinium Therapeutics Inc
AVG HISTORICAL GAP
-1.11%
MAX GAP RECORD
-6.38%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DFTX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DFTX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+0.35%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-1.47%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
-1.62%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-3.35%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (AFTER CLOSE) |
-6.38%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+0.63%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (BEFORE OPEN) |
-5.02%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+2.26%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.8%
Bullish Gaps (4)
Bearish Gaps (8)
Neutral / Flat (3)
📖 Intelligence Summary
Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗